Table 2 |
|||
|
Events Table for the Ischemic Stroke Genetics Study |
|||
|
Enrollment |
90 ± 14 days after stroke |
||
|
|
|
||
|
Variables |
Cases |
Controls |
Cases |
|
|
|||
|
Structured interview |
|||
|
Demographics |
X |
X |
|
|
Medications |
X |
X |
|
|
Family history |
X |
X |
|
|
Past medical history |
X |
X |
|
|
Social and behavioral history |
X |
X |
|
|
QVSS |
X |
X |
|
|
Blood sample |
X |
X |
|
|
Medical records |
|||
|
Vital signs |
X |
||
|
Laboratory tests |
X |
||
|
Head imaging |
X |
||
|
Vascular imaging |
X |
||
|
Treatments |
X |
||
|
Stroke status |
|||
|
Subtyping |
X |
||
|
Time of stroke onset |
X |
||
|
NIH Stroke Scale |
X |
||
|
Barthel Index |
X |
T |
|
|
Oxford Handicap Scale |
X |
T |
|
|
Glasgow Outcome Scale |
X |
T |
|
|
|
|||
|
NIH, National Institutes of Health; QVSS, Questionnaire for Verifying Stroke-free Status; T, assessment by telephone; X, assessment by face-to-face interview or examination. |
|||
|
Meschia et al. BMC Neurology 2003 3:4 doi:10.1186/1471-2377-3-4 |
|||
